Impact of Hypertension on the Prognosis of COVID-19 Disease and Uncertainties that Need to be Clarified

Saylik F Akbulut T Kaya S . Can c-reactive protein to albumin ratio predict in-hospital death rate due to COVID-19 in patients with hypertension? Angiology. 2021 Apr 27:000331972110121. doi:10.1177/00033197211012145. Online ahead of print.

WHO . The Novel Coronavirus Pneumonia Emergency Response Epidemiology T. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41:145-151.

Clark CE McDonagh STJ McManus RJ Martin U . COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish hypertension society. J Hum Hypertens. 2021;35:304-307.

Chen T Wu D Chen H , et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m1091; Erratum in: BMJ. 2020;368:m1295.

Guo T Fan Y Chen M , et al Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5:811-818.

Sun Y Guan X Jia L , et al. Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID‐19: a retrospective cohort study of Huoshen mountain hospital and Guanggu fangcang shelter hospital. J Clin Hypertens. 2021;23:218-231.

Williamson EJ Walker AJ Bhaskaran K , et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430-436.

Ran J Song Y Zhuang Z , et al. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertens Res. 2020; 43:1267-1276.

Chen R Yang J Gao X , et al. Influence of blood pressure control and application of renin‐angiotensin‐aldosterone system inhibitors on the outcomes in COVID‐19 patients with hypertension. J Clin Hypertens. 2020;22:1974-1983.

Shibata S Arima H Asayama K , et al. Hypertension and related diseases in the era of COVID-19: a report from the Japanese society of hypertension task force on COVID-19. Hypertens Res. 2020;43:1028-1046.

Deng Y Liu W Liu K , et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chinese Med J. 2020;133:1261-1267.

Liu Y Yang Y Zhang C , et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364-374.

Liu W Tao Z-W Wang L , et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Med J. 2020;133:1032-1038.

Güney BÇ YÖ Taştan Doğantekin B , et al. Predictive value of CAR for In-Hospital Mortality in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study. Arch Med Res. 2021;S0188-4409(21)00041-00042. doi: 10.1016/j.arcmed.2021.02.006.